ASSESSMENT OF LIVER ENZYMES FOR THE DIAGNOSIS OF MICROCYSTIN INDUCED HEPATOTOXICITY IN THE SETTING OF PRE-EXISTING LIVER DISEASE

被引:0
|
作者
Su, Robin [1 ]
Lad, Apurva [1 ]
Kleinhenz, Andrew [1 ]
Haller, Steven T. [1 ]
Kennedy, David J. [1 ]
机构
[1] Univ Toledo, Coll Med & Life Sci, 2801 W Bancroft St, Toledo, OH 43606 USA
关键词
D O I
10.1136/jim-2019-midwestern2019.52
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
A29
引用
收藏
页码:895 / 895
页数:1
相关论文
共 50 条
  • [21] Tamoxifen (TMX)-induced hepatotoxicity in breast cancer (BC) patients with pre-existing liver steatosis (LS). The role of glucose intolerance.
    Elefsiniotis, IS
    Pantazis, KD
    Ilias, A
    Pallis, L
    Mariolis, A
    Glynou, I
    Kada, H
    Moulakakis, A
    JOURNAL OF HEPATOLOGY, 2004, 40 : 171 - 172
  • [22] ENZYMES IN DIAGNOSIS OF LIVER DISEASE
    SCHMIDT, FW
    PROCEEDINGS OF THE ROYAL SOCIETY OF MEDICINE-LONDON, 1967, 60 (12): : 1247 - &
  • [23] COVID-19 in patients with pre-existing chronic liver disease–predictors of outcomes
    Dinesh Walia
    Anoop Saraya
    Deepak Gunjan
    World Journal of Virology, 2023, (01) : 30 - 43
  • [24] 6-Mercaptopurine-Induced Non-Cirrhotic Portal Hypertension With Rapid Progression to Liver Cirrhosis in the Absence of Pre-Existing Liver Disease
    Chiejina, Maria
    Samant, Hrishikesh
    Bienvenu, John
    Wellman, Greg
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2018, 113 : S1270 - S1270
  • [25] Pre-existing liver diseases lead acute HEV infection to progressive liver failure
    Kang, Jong-Hon
    Matsui, Takeshi
    Nagai, Kazumasa
    Tomonari, Akiko
    Tanaka, Kazunari
    Tsuji, Kunihiko
    Maguchi, HIroyuki
    Karino, Yoshiyasu
    Ozeki, Itaru
    Hige, Shuhei
    Nakajima, Tomoaki
    Ohmura, Takumi
    Takahashi, Kazuaki
    Arai, Masahiro
    Mishiro, Shunji
    HEPATOLOGY, 2014, 60 : 562A - 562A
  • [26] IDIOSYNCRATIC DRUG-INDUCED LIVER INJURY (DILI) IN PATIENTS WITH PRE-EXISTING LIVER DISEASE: AN ANALYSIS OF THE CASES INCLUDED IN THE SPANISH DILI REGISTRY
    Ortiz-Lopez, N.
    Garcia-Munoz, B.
    Borraz, Y.
    Robles, M.
    Castiella, A.
    Fernandez, M. C.
    Perez-Alvarez, R.
    Blanco, S.
    Avila, S.
    Lucena, M. I.
    Andrade, R. J.
    BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY, 2011, 109 : 64 - 64
  • [27] IDIOSYNCRATIC DRUG-INDUCED LIVER INJURY (DILI) IN PATIENTS WITH PRE-EXISTING LIVER DISEASE: AN ANALYSIS OF THE CASES INCLUDED IN THE SPANISH DILI REGISTRY
    Ortiz Lopez, N.
    Garcia-Munoz, B.
    Borraz, Y.
    Roble, M.
    Castiella, A.
    Fernandez, M. D. C.
    Perez-Alvarez, R.
    Blanco, S.
    Avila, S.
    Lucena, M. I.
    Andrade, R. J.
    JOURNAL OF HEPATOLOGY, 2011, 54 : S199 - S199
  • [28] Is Pre-Existing Liver Cirrhosis and Fibrosis a Contraindication to Heart Transplantation?
    Sasevich, M. J.
    Esmailian, F.
    Rihbany, K.
    Pouldar, T.
    Yu, Z.
    Liou, F.
    Ramzy, D.
    Arabia, F.
    Trento, A.
    Czer, L.
    Hamilton, M.
    Kobashigawa, J.
    JOURNAL OF HEART AND LUNG TRANSPLANTATION, 2014, 33 (04): : S157 - S157
  • [29] Pre-existing diabetes (PED) in liver transplant patients (LTP)
    Coppelli, Alberto
    Giannarelli, Rosa
    Coletti, Laura
    Morelli, Luca
    Urbani, Lucio
    Petruccelli, Stefania
    Catalano, Gabriele
    De Simone, Paolo
    Del Prato, Stefano
    Mosca, Franco
    Filipponi, Franco
    Marchetti, Piero
    DIABETES, 2007, 56 : A719 - A719
  • [30] HIGHER PRE-TREATMENT ALT LEVEL AND PRE-EXISTING LIVER DISEASE ARE ASSOCIATED WITH INCREASED RISKS OF FLUCONAZOLE RELATED LIVER TOXICITY
    Hsieh, Pinghsin
    Hsu, Yao-Chun
    HEPATOLOGY, 2024, 80 : S944 - S945